Federal Circuit finds Millennium’s cancer drug to be novel

18-07-2017

Federal Circuit finds Millennium’s cancer drug to be novel

vladimirsorokin / iStockphoto.com

The US Court of Appeals for the Federal Circuit has reversed and remanded a decision from a district court which ruled that a patented Millennium Pharmaceuticals cancer drug was invalid.


Millennium Pharmaceuticals, cancer, Federal Circuit, ANDA, FDA, Sandoz, Mylan, Dr Reddy’s, Sun Pharma,

LSIPR